Anticholinergic Risk and Frequency of Anticholinergic Drug Prescriptions in a Population Older Than 65

Abstract Objective To determine the risk and frequency of anticholinergic drug prescriptions in a population affiliated with the Colombian General System of Social Security in Health. Design A cross-sectional study was conducted in 2013. Participants Patients older than 65 years who received drugs w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Medical Directors Association 2016-03, Vol.17 (3), p.275.e1-275.e4
Hauptverfasser: Machado-Alba, Jorge Enrique, MD, Castro-Rodríguez, Alejandro, MD, Álzate-Piedrahita, John Alexander, MD, Hoyos-Pulgarín, Julián Andrés, MD, Medina-Morales, Diego Alejandro, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Objective To determine the risk and frequency of anticholinergic drug prescriptions in a population affiliated with the Colombian General System of Social Security in Health. Design A cross-sectional study was conducted in 2013. Participants Patients older than 65 years who received drugs with the potential to block cholinergic receptors, in accordance with an anticholinergic risk scale. Measurements The total anticholinergic load was determined by the sum of the risk of each prescribed drug. Results The study included a total of 27,654 patients with a mean age of 76.1 ± 7.6 years, and 61.9% were women. A total of 9.1% of the population older than 65 years had received a prescription of at least one of these drugs, and the prevalence of these prescriptions was 112.5 per 1000 members. The average number of drugs prescribed per patient was 1.4, and the drugs most frequently prescribed contained trazodone, methocarbamol, and loratadine. Being prescribed by practitioners of surgical or related specialties was the only variable significantly associated with prescriptions with high anticholinergic risk in the multivariate analysis (odds ratio 1.61; 95% confidence interval 1.335–1.934; P  
ISSN:1525-8610
1538-9375
DOI:10.1016/j.jamda.2015.12.003